Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
August 24, 2021	8-K	Report of unscheduled material events or corporate event	0001193125-21-254567.pdf 0001193125-21-254567.rtf 0001193125-21-254567.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 10, 2021	SC 13G/A	An amendment to the SC 13G filing	0000902219-21-000380.pdf 0000902219-21-000380.rtf 0000902219-21-000380.xls View HTML
August 5, 2021	8-K	Report of unscheduled material events or corporate event	0001193125-21-237047.pdf 0001193125-21-237047.rtf 0001193125-21-237047.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 5, 2021	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-21-015865.pdf 0001628280-21-015865.rtf 0001628280-21-015865.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
July 12, 2021	SC 13G/A	An amendment to the SC 13G filing	0000093751-21-000625.pdf 0000093751-21-000625.rtf View HTML
June 9, 2021	4	Statement of changes in beneficial ownership of securities	0001562180-21-004152.pdf 0001562180-21-004152.rtf View HTML
June 3, 2021	8-K	Report of unscheduled material events or corporate event	0001193125-21-180654.pdf 0001193125-21-180654.rtf 0001193125-21-180654.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
June 3, 2021	4	Statement of changes in beneficial ownership of securities	0001562180-21-004028.pdf 0001562180-21-004028.rtf 0001562180-21-004028.xls View HTML
June 3, 2021	4	Statement of changes in beneficial ownership of securities	0001562180-21-004027.pdf 0001562180-21-004027.rtf 0001562180-21-004027.xls View HTML
June 3, 2021	4	Statement of changes in beneficial ownership of securities	0001562180-21-004026.pdf 0001562180-21-004026.rtf 0001562180-21-004026.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax